Published in Kidney Int on July 01, 1980
Evidence for a circulating sodium transport inhibitor in essential hypertension. Br Med J (Clin Res Ed) (1981) 1.84
Haemodialysis related osteomalacia: a staining method to demonstrate aluminium. J Clin Pathol (1981) 1.67
Sodium and potassium in essential hypertension. Br Med J (Clin Res Ed) (1981) 1.18
The sodium pump and cardiotonic steroids-induced signal transduction protein kinases and calcium-signaling microdomain in regulation of transporter trafficking. Biochim Biophys Acta (2010) 1.17
Demonstration of aluminium in iliac bone: correlation between aluminon and solochrome azurine staining techniques with data on flameless absorption spectrophotometry. J Clin Pathol (1988) 1.07
Positive inotropic effects of the endogenous Na+/K(+)-transporting ATPase inhibitor from the hypothalamus. Proc Natl Acad Sci U S A (1989) 0.97
Race and sex differences in erythrocyte Na+, K+, and Na+-K+-adenosine triphosphatase. J Clin Invest (1985) 0.94
Evidence for a raised concentration of a circulating sodium transport inhibitor in essential hypertension. Br Med J (Clin Res Ed) (1981) 0.92
Reactive Oxygen Species Modulation of Na/K-ATPase Regulates Fibrosis and Renal Proximal Tubular Sodium Handling. Int J Nephrol (2012) 0.90
Effect of ouabain on tone, membrane potential and sodium efflux compared with [3H]ouabain binding in rat resistance vessels. J Physiol (1985) 0.90
Relation between arterial pressure, dietary sodium intake, and renin system in essential hypertension. Br Med J (Clin Res Ed) (1981) 0.88
Intracellular ionic consequences of dietary salt loading in essential hypertension. Relation to blood pressure and effects of calcium channel blockade. J Clin Invest (1994) 0.83
Endogenous digitalis-like factors: an overview of the history. Front Endocrinol (Lausanne) (2015) 0.80
Diffuse structural alterations in cell membranes of spontaneously hypertensive rats. Proc Natl Acad Sci U S A (1982) 0.80
The pathogenesis of hypertension in obese subjects. Drugs (1993) 0.80
Sodium transport inhibitors in pregnancy-induced hypertension. Cardiovasc Drugs Ther (1990) 0.79
Essential hypertension in blacks: epidemiology, characteristics, and possible roles of racial differences in sodium, potassium, and calcium regulation. Cardiovasc Drugs Ther (1990) 0.78
Effect of subthreshold ouabain on the tone of guinea-pig aortic strips following repeated noradrenaline stimulation. Br J Pharmacol (1994) 0.78
The kidney and arterial hypertension. Drugs (1993) 0.78
Effect of inhibition of Na+/K(+)-adenosine triphosphatase on vascular action of vasopressin. J Clin Invest (1990) 0.77
Atrial natriuretic factor: a new hormone? Br Med J (Clin Res Ed) (1984) 0.76
Renal effects of TAPP, a highly selective mu-opioid agonist. Br J Pharmacol (1996) 0.75
Alterations of erythrocyte ATPase activity and oxygen consumption in patients with liver-blood deficiency syndrome. World J Gastroenterol (1997) 0.75
Ouabain and responses to endothelium-dependent vasodilators in the human forearm. Br J Clin Pharmacol (1991) 0.75
Blood pressure and the kidney. J Clin Pathol (1981) 0.75
Glimpses of the mechanisms of hypertension. Br Med J (Clin Res Ed) (1986) 0.75
Noradrenaline: a circulating inhibitor of sodium transport. Br Med J (Clin Res Ed) (1984) 0.75
Effect of treatment with chlorthalidone and atenolol on response to dilator agents in the forearm resistance vessels of men with primary hypertension. Br J Clin Pharmacol (1983) 0.75
Sodium and hypertension. Still a controversy in 1986. Drugs (1986) 0.75
Erythrocyte concentrations and transmembrane fluxes of sodium and potassium in essential hypertension: role of intrinsic and environmental factors. Cardiovasc Drugs Ther (1990) 0.75
British Hypertension Society guidelines for hypertension management 1999: summary. BMJ (1999) 8.80
A comprehensive review on salt and health and current experience of worldwide salt reduction programmes. J Hum Hypertens (2008) 6.82
Survey of use of anticoagulation in patients with atrial fibrillation. BMJ (1993) 5.71
Effect of modest salt reduction on blood pressure: a meta-analysis of randomized trials. Implications for public health. J Hum Hypertens (2002) 4.93
Double-blind randomised trial of modest salt restriction in older people. Lancet (1997) 3.96
Effect of longer-term modest salt reduction on blood pressure. Cochrane Database Syst Rev (2004) 3.90
Increased consumption of fruit and vegetables is related to a reduced risk of coronary heart disease: meta-analysis of cohort studies. J Hum Hypertens (2007) 3.20
Renal artery stenosis masquerading as congestive heart failure. Lancet (1993) 3.10
Double-blind randomised crossover trial of moderate sodium restriction in essential hypertension. Lancet (1982) 3.07
Sarcoidosis, thyroiditis, and Addison's disease. Lancet (1970) 2.84
Better blood pressure control: how to combine drugs. J Hum Hypertens (2003) 2.19
Salt--more adverse effects. Lancet (1996) 2.17
Maintenance haemodialysis. Q J Med (1969) 2.13
Is "idiopathic" edema idiopathic? Lancet (1979) 2.11
A syndrome of loin pain and haematuria associated with disease of peripheral renal arteries. Q J Med (1967) 1.98
Phenacetin nephropathy, with particular reference to the effect of surgery. Br Med J (1970) 1.97
Diuretic-induced oedema. Lancet (1975) 1.84
Evidence for a circulating sodium transport inhibitor in essential hypertension. Br Med J (Clin Res Ed) (1981) 1.84
Moderate potassium supplementation in essential hypertension. Lancet (1982) 1.83
Echocardiography overestimates left ventricular mass: a comparative study with magnetic resonance imaging in patients with hypertension. J Hypertens (1996) 1.81
Measurement of plasma renin activity by radioimmunoassay after prolonged cold storage. Clin Chim Acta (1978) 1.77
The measurement of angiotensin-converting enzyme in subjects receiving captopril. N Engl J Med (1980) 1.72
Familial Guillain-Barré syndrome. Lancet (1965) 1.71
Fortnightly review: Beneficial effects of potassium. BMJ (2001) 1.59
Cost of poor blood pressure control in the UK: 62,000 unnecessary deaths per year. J Hum Hypertens (2003) 1.59
Cancer in patients receiving dialysis. Br Med J (1980) 1.52
Platelet volume is not increased in essential hypertension. J Hum Hypertens (1994) 1.48
Hepatitis in a maintenance hemodialysis unit. Ann Intern Med (1968) 1.44
Mineralocorticoid deficiency in HIV infection. BMJ (1989) 1.43
Maintenance of blood pressure by the renin-angiotensin system in normal man. Nature (1981) 1.42
Association of hypertension with T594M mutation in beta subunit of epithelial sodium channels in black people resident in London. Lancet (1998) 1.42
Does potassium supplementation lower blood pressure? A meta-analysis of published trials. J Hypertens (1991) 1.39
Potassium softens vascular endothelium and increases nitric oxide release. Proc Natl Acad Sci U S A (2009) 1.38
Effects of changes in dietary sodium intake and saline infusion on immunoreactive atrial natriuretic peptide in human plasma. Lancet (1985) 1.38
The use of HMG Co-A reductase inhibitors following acute myocardial infarction in hospital practice. Postgrad Med J (1998) 1.37
Renal artery stenosis: a common and important problem in patients with peripheral vascular disease. Am J Med (1994) 1.37
Follow-up of 164 patients with bacteriuria of pregnancy. Lancet (1968) 1.33
Raised circulating levels of atrial natriuretic peptides in essential hypertension. Lancet (1986) 1.32
Post meningococcal acute glomerular nephritis. Clin Nephrol (1978) 1.31
Sodium is more important than calcium in essential hypertension. Hypertension (1985) 1.26
Concept of natriuretic hormone. Physiol Rev (1985) 1.23
Structural skin capillary rarefaction in essential hypertension. Hypertension (1999) 1.21
Long term reduction in sodium balance: possible additional mechanism whereby nifedipine lowers blood pressure. BMJ (1990) 1.21
Sodium restriction lowers high blood pressure through a decreased response of the renin system--direct evidence using saralasin. J Hypertens (1985) 1.21
Captopril in essential hypertension; contrasting effects of adding hydrochlorothiazide or propranolol. Br Med J (Clin Res Ed) (1982) 1.18
The therapeutic effect of taking a patient's history by computer. J R Coll Gen Pract (1977) 1.16
Rarefaction of skin capillaries in normotensive offspring of individuals with essential hypertension. Heart (2003) 1.16
Rarefaction of skin capillaries in borderline essential hypertension suggests an early structural abnormality. Hypertension (1999) 1.15
Importance of the renin system in determining blood pressure fall with salt restriction in black and white hypertensives. Hypertension (1998) 1.15
Essential hypertension: effect of an oral inhibitor of angiotensin-converting enzyme. Br Med J (1979) 1.14
Survival in 200 patients treated by haemodialysis and renal transplantation. Br Med J (1977) 1.13
Hyperthyroidism and a parathyroid adenoma complicating lithium treatment. Lancet (1977) 1.12
Lack of histological evidence of vitamin D abnormality in the bones of anephric patients. Clin Sci (1973) 1.11
Normal plasma-1,25-(OH)2-vitamin-D concentrations in nutritional osteomalacia. Lancet (1979) 1.11
The effect of urine osmolality and pH on the bactericidal activity of plasma. Clin Sci (1967) 1.09
Dietary salt and blood pressure. Lancet (1994) 1.08
Agonist and antagonist effects of Sar1-ala8--angiotensin II in salt-loaded and salt-depleted normal man. Br J Clin Pharmacol (1976) 1.08
Maximization of skin capillaries during intravital video-microscopy in essential hypertension: comparison between venous congestion, reactive hyperaemia and core heat load tests. Clin Sci (Lond) (1999) 1.04
Moderate sodium restriction with angiotensin converting enzyme inhibitor in essential hypertension: a double blind study. Br Med J (Clin Res Ed) (1987) 1.04
Plasma concentrations and comparisons of brain and atrial natriuretic peptide in normal subjects and in patients with essential hypertension. J Hum Hypertens (1993) 1.04
Effect of salt intake on renal excretion of water in humans. Hypertension (2001) 1.04
Control of sodium reabsorption. Br Med J (1969) 1.02
Effect of sodium intake on ability of human plasma to inhibit renal Na+-K+-adenosine triphosphatase in vitro. Lancet (1981) 1.02
Moderate potassium chloride supplementation in essential hypertension: is it additive to moderate sodium restriction? Br Med J (Clin Res Ed) (1985) 1.01
Capillary rarefaction in the forearm skin in essential hypertension. J Hypertens (1995) 1.01
A randomized crossover study to compare the blood pressure response to sodium loading with and without chloride in patients with essential hypertension. J Hypertens (1988) 1.01
A family with autosomal dominant polycystic kidney disease not linked to chromosome 16p13.3. Clin Genet (1993) 1.00
Diuretics and oedema: how to avoid rebound sodium retention. Lancet (1992) 1.00
Contrasting effects of nifedipine, captopril, and propranolol in normotensive and hypertensive subjects. J Cardiovasc Pharmacol (1982) 0.99
Captopril: contrasting effects of adding hydrochlorothiazide, propranolol, or nifedipine. J Cardiovasc Pharmacol (1985) 0.98
Non-sulfhydryl-containing angiotensin-converting enzyme inhibitor (MK421): evidence for role of renin system in normotensive subjects. Br Med J (Clin Res Ed) (1981) 0.98
Lack of effect of oral magnesium on high blood pressure: a double blind study. Br Med J (Clin Res Ed) (1985) 0.98
Physiology: cardiac peptides and the control of sodium excretion. Nature (1984) 0.97
Angiotensin converting enzyme gene I/D polymorphism, blood pressure and the renin-angiotensin system in Caucasian and Afro-Caribbean peoples. J Hum Hypertens (1996) 0.97
Acute and sustained changes in sodium balance during nifedipine treatment in essential hypertension. Am J Med (1991) 0.96
Dietary sodium and potassium intake and blood pressure. Lancet (1983) 0.96
Effects of amlodipine on urinary sodium excretion, renin-angiotensin-aldosterone system, atrial natriuretic peptide and blood pressure in essential hypertension. J Hum Hypertens (1991) 0.95
Letter: Saralasin bolus test. Lancet (1975) 0.95
Sodium and blood pressure. Curr Opin Cardiol (2002) 0.95
The natriuretic hormone and essential hypertension. Lancet (1982) 0.94
Reduction of salt intake during converting enzyme inhibitor treatment compared with addition of a thiazide. Hypertension (1995) 0.94
Slow sodium: an oral slowly released sodium chloride preparation. Br Med J (1971) 0.94
Transepithelial sodium absorption is increased in people of African origin. Hypertension (2001) 0.94
Interested in developing a national programme to reduce dietary salt? J Hum Hypertens (2011) 0.93
The acute response to nifedipine is related to pre-treatment blood pressure. Postgrad Med J (1983) 0.93
Experience in the computer handling of clinical data for dialysis and transplantation units. Kidney Int (1983) 0.92
Importance of the renin system for determining blood pressure fall with acute salt restriction in hypertensive and normotensive whites. Hypertension (2001) 0.92
Evidence for a raised concentration of a circulating sodium transport inhibitor in essential hypertension. Br Med J (Clin Res Ed) (1981) 0.92
Phenformin and metabolic acidosis. Lancet (1972) 0.92
Cognitive impairment and white matter damage in hypertension: a pilot study. Acta Neurol Scand (2008) 0.91
Transient and persistent hypercalcaemia in patients treated by maintenance haemodialysis. Br Med J (1968) 0.91
Control of sodium reabsorption. Br Med J (1969) 0.91
Harmful effects of dietary salt in addition to hypertension. J Hum Hypertens (2002) 0.91
Azathioprine for myasthenia gravis. Lancet (1972) 0.91